Beeio Honey Ltd
ORCT
OTC PK
| Weiss Ratings | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | E | |||
| Rating Factors | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.00 | |||
| Price History | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 0.00% | |||
| 2-Year Total Return | 0.00% | |||
| 3-Year Total Return | 0.00% | |||
| 5-Year Total Return | 0.00% | |||
| 52-Week High % Change | -16.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Sep 22, 2023 | |||
| 52-Week High Price (Date) | Sep 22, 2023 | |||
| Valuation | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | $6.14M | |||
| Enterprise Value | 6.90M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.27 | |||
| Earnings Per Share Growth | -88.85% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.01 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -2.95 | |||
| Enterprise Value/EBIT | -2.74 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 17.224M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 972 8 613 1198 | |||
| Address | -- | |||
| Website | bee-io.com | |||
| Country | Israel | |||
| Year Founded | 1990 | |||
| Profitability | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -58.41% | |||
| Return on Equity | -- | |||
| Income Statement | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -$4.11M | |||
| EBIT (TTM) | -$4.44M | |||
| Net Income (TTM) | -$4.46M | |||
| Net Income Avl. to Common (TTM) | -$4.46M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -10.94% | |||
| EPS Diluted (TTM) | -$0.27 | |||
| EPS Diluted Growth (Q YOY) | 21.02% | |||
| Balance Sheet | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | $1.88M | |||
| Cash Per Share (Q) | $0.11 | |||
| Total Current Assets (Q) | $1.98M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | $2.63M | |||
| Current Ratio (Q) | 3.923 | |||
| Book Value Per Share (Q) | $0.14 | |||
| Total Assets (Q) | $4.66M | |||
| Total Current Liabilities (Q) | $503.70K | |||
| Total Debt (Q) | $1.68M | |||
| Total Liabilities (Q) | $2.03M | |||
| Total Common Equity (Q) | $2.63M | |||
| Cash Flow | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -$519.40K | |||
| Cash from Financing (TTM) | $5.19M | |||
| Net Change in Cash (TTM) | $1.28M | |||
| Levered Free Cash Flow (TTM) | -$1.20M | |||
| Cash from Operations (TTM) | -$3.39M | |||
